Powered by RND
PodcastsSaúde e fitnessMedical Digest & Congress Report

Medical Digest & Congress Report

Medical Congress News
Medical Digest & Congress Report
Último episódio

Episódios Disponíveis

5 de 563
  • DYNAMIC-III trial results: ctDNA blood test is a powerful tool to guide treatment choices for people with advanced colon cancer - report from ESMO 2025
    Professor Jeanne Tie shares her thoughts on the DYNAMIC-III trial results were presented at the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:dynamic-iii-trial-results-ctdna-blood-test-powerful-tool-guide-treatment-choices-people-advanced-colon-cancer
    --------  
    6:18
  • Overcoming Therapeutic Challenges in High-risk Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Approach - report from ESMO 2025
    Professor Dirk Schadendorf shares his thoughts on the overcoming therapeutic challenges in high-risk cutaneous squamous cell carcinoma at the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:overcoming-therapeutic-challenges-high-risk-cutaneous-squamous-cell-carcinoma-multidisciplinary-approach
    --------  
    7:09
  • KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials - report from ESMO 2025
    Professor Christof Vulsteke shares her thoughts on the data from the phase 3 KEYNOTE-905 trial were presented at the ESMO Congress 2025. A treatment regimen consisting of neoadjuvant enfortumab vedotin-ejfv plus pembrolizumab, radical cystectomy plus pelvic lymph node dissection, and adjuvant EV plus pembrolizumab yielded significant improvements in multiple outcomes in patients with muscle-invasive bladder cancer who are ineligible for or decline cisplatin-based chemotherapy.Video: https://medicaldigest.org/scientific-contents/interview:keynote-905-paves-way-next-generation-mibc-trials
    --------  
    4:14
  • Durvalumab in Combination with BCG for BCG-Naïve High-Risk NMIBC: Final Analysis of the Phase 3, Open-Label, Randomized POTOMAC Trial - report from ESMO 2025
    Professor Maria De Santis shares her thoughts on the final analysis of the phase 3, open-Label, randomized POTOMAC trial were presented at the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:durvalumab-combination-bcg-bcg-naive-high-risk-nmibc-final-analysis-phase-3-open-label-randomized-potomac-trial
    --------  
    3:35
  • Treatment Landscape in Resectable LA HNSCC - report from ESMO 2025
    Professor Hisham M. Mehanna shares his thoughts on the treatment landscape in resectable LA HNSCC at ESMO 2005 at the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:treatment-landscape-resectable-la-hnscc
    --------  
    6:10

Mais podcasts de Saúde e fitness

Sobre Medical Digest & Congress Report

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
Site de podcast

Ouça Medical Digest & Congress Report, Cartas de um Terapeuta e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções

Medical Digest & Congress Report: Podcast do grupo

Aplicações
Social
v7.23.11 | © 2007-2025 radio.de GmbH
Generated: 11/14/2025 - 12:19:13 AM